|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
N/A
|
(NCI)
|
|
Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NP
|
5R01CA115873-05
|
$498,801
|
ADAMI, HANS-OLOV
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
FISH assay identifying oral cancer patients at low risk of lymph node metastasis
|
1R21CA163019-01A1
|
$215,021
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Bladder Cancer Risk and Genomic Alterations
|
5R01CA089715-10
|
$359,776
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
5P01CA151135-02
|
$3,641,180
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIABC010887
|
$294,527
|
Ambs, Stefan
|
CCR (NCI)
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
7U19CA148127-03
|
$2,636,071
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
Adult Leukemia Research Center
|
2P01CA018029-37A1
|
$4,225,448
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Racial Differences in BRCA1/2 Testing: Patients or Providers?
|
5R01CA133004-04
|
$464,663
|
ARMSTRONG, KATRINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Familial Gastric Cancer: Diagnosis, DNA Sequencing, Early detection
|
ZIABC011341
|
$51,632
|
Avital, Itzhak
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-23S1
|
$75,000
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-23
|
$1,454,512
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Vitamin D and Colorectal Cancer
|
5R01CA122299-05
|
$335,470
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
RRM1 in the Management of Lung Cancer
|
5R01CA129343-05
|
$1
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
BRAIN TUMOR SPORE GRANT
|
3P50CA097257-10S1
|
$599,883
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-21
|
$258,854
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Brain Tumors - Immunological and Biological Studies
|
5R37CA011898-42
|
$681,848
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-17
|
$332,512
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
Breast Cancer Risk: Analysis of heightened HPA axis stress responsivity
|
5R01CA129557-05
|
$375,465
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Communicating Genetic Test Results by Telephone: A Randomized Trial
|
1R01CA160847-01A1
|
$668,104
|
Bradbury, Angela
|
UNIVERSITY OF PENNSYLVANIA
|
|
Virtual Cancer Genetic Services: Telemedicine Delivery in Community Clinics
|
1R21CA164121-01A1
|
$227,184
|
Bradbury, Angela
|
UNIVERSITY OF PENNSYLVANIA
|
|
Great Lakes/New England Clinical Validation Center
|
3U01CA086400-13S1
|
$109,792
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Great Lakes/New England Clinical Validation Center
|
5U01CA086400-13
|
$691,268
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
2R01CA054498-21A1
|
$714,157
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers
|
5R03CA157212-02
|
$84,884
|
Buchanan, Adam
|
DUKE UNIVERSITY
|
|
Investigating the role of retrotransposons in hematopoietic neoplasias.
|
5K08CA134746-05
|
$141,345
|
BURNS, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Experimental Therapeutics of Leukemia
|
5P50CA140158-04
|
$2,294,169
|
BYRD, JOHN
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-36S1
|
$49,250
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-36S2
|
$140,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-36S3
|
$75,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-36
|
$4,582,303
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
|
1R01CA163353-01A1
|
$612,611
|
CAMP, NICOLA
|
UNIVERSITY OF UTAH
|
|
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
|
5R01CA134674-03
|
$558,420
|
CAMP, NICOLA
|
UNIVERSITY OF UTAH
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-13
|
$1,150,000
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Cancer Center Support Grant
|
5P30CA016087-32
|
$2,512,026
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers
|
5U24CA160036-02
|
$1,875,068
|
CHAN, DANIEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Integrative prediction models for metastasis risk in colon cancer
|
1R01CA158472-01A1
|
$469,030
|
Chen, Xi
|
VANDERBILT UNIVERSITY MED CTR
|
|
Study the Role of DNA Damage Responses in Tumorigenesis
|
5R01CA092312-14
|
$236,801
|
CHEN, JUNJIE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
N01PC100030-007
|
$1,705,139
|
CHEN, VIVIEN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Mechanisms of RelA Activation in Cancer
|
5R01CA097159-08
|
$218,253
|
CHIAO, PAUL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Prostate Cancer
|
5P50CA069568-15
|
$2,300,000
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
B-cell repertoires in chronic lymphocytic leukemia
|
5R01CA081554-09
|
$311,150
|
Chiorazzi, Nicholas
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
A novel model system for risk assessment of BRCA carriers
|
1F31CA168180-01
|
$42,232
|
Cochran, Rory
|
JOHNS HOPKINS UNIVERSITY
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
3R01CA079830-11S1
|
$22,311
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-11
|
$320,196
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Mitochondrial DNA and Ovarian Cancer Risk and Survival
|
1R01CA160669-01A1
|
$542,855
|
Cook, Linda
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|